Literature DB >> 28551806

Mitochondrial Dysfunction in the Diabetic Kidney.

Kumar Sharma1,2.   

Abstract

The role of mitochondria in diabetic complications has been viewed as a source of excess superoxide production leading to cell dysfunction. However, with the lack of benefit of non-specific anti-oxidant approaches this view needs to be re-evaluated. With recent studies using real-time imaging of superoxide, metabolomics, flux studies, transcriptomics and proteomics a new appreciation for the role of mitochondria in the evolution of diabetic kidney disease has emerged. Ongoing studies to further unravel the time course and mechanisms that reduce mitochondrial function will be relevant to novel therapies that could have a major impact on diabetic kidney disease and other diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28551806     DOI: 10.1007/978-3-319-55330-6_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  C3a receptor blockade protects podocytes from injury in diabetic nephropathy.

Authors:  Marina Morigi; Luca Perico; Daniela Corna; Monica Locatelli; Paola Cassis; Claudia Elisa Carminati; Silvia Bolognini; Carlamaria Zoja; Giuseppe Remuzzi; Ariela Benigni; Simona Buelli
Journal:  JCI Insight       Date:  2020-03-12

2.  Comprehensive assessment of mitochondrial respiratory function in freshly isolated nephron segments.

Authors:  Allison McCrimmon; Mark Domondon; Regina F Sultanova; Daria V Ilatovskaya; Krisztian Stadler
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-30

3.  Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells.

Authors:  Yifan Xie; Jing E; Hong Cai; Fang Zhong; Wenzhen Xiao; Ronald E Gordon; Lois Wang; Ya-Li Zheng; Aihua Zhang; Kyung Lee; John Cijiang He
Journal:  Kidney Int       Date:  2022-04-22       Impact factor: 18.998

Review 4.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

Review 5.  The Warburg Effect in Diabetic Kidney Disease.

Authors:  Guanshi Zhang; Manjula Darshi; Kumar Sharma
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

6.  Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.

Authors:  Xu-Shun Jiang; Xing-Yang Xiang; Xue-Mei Chen; Jun-Ling He; Ting Liu; Hua Gan; Xiao-Gang Du
Journal:  Cell Death Dis       Date:  2020-05-21       Impact factor: 8.469

Review 7.  Catalytic Antioxidants in the Kidney.

Authors:  Yu Ah Hong; Cheol Whee Park
Journal:  Antioxidants (Basel)       Date:  2021-01-18

8.  Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.

Authors:  Louise Woodhams; Tin Fei Sim; Leanne Chalmers; Bu Yeap; Daniel Green; Markus Schlaich; Carl Schultz; Graham Hillis
Journal:  PeerJ       Date:  2021-04-19       Impact factor: 2.984

9.  Intact mitochondrial substrate efflux is essential for prevention of tubular injury in a sex-dependent manner.

Authors:  Allison McCrimmon; Kerin M Cahill; Claudia Kruger; Margaret E Mangelli; Emily Bouffard; Timothy Dobroski; Kelly N Michanczyk; Susan J Burke; Robert C Noland; Daria V Ilatovskaya; Krisztian Stadler
Journal:  JCI Insight       Date:  2022-04-08

10.  Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism.

Authors:  Wen-Chin Lee; You-Ying Chau; Hwee-Yeong Ng; Chiu-Hua Chen; Pei-Wen Wang; Chia-Wei Liou; Tsu-Kung Lin; Jin-Bor Chen
Journal:  Cells       Date:  2019-09-14       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.